AZothBio (에이조스바이오)
Hanam-si, South Korea
Based on the AI-BIO platform has established the new drug development platform for compound screening such as new small molecules, macromolecules such as peptides and proteins, and phenotype-based anticancer compounds, and for predicting the suitability of new drugs. We want to contribute to the advancement of medical care by minimizing the time required to develop new drugs for pharmaceutical companies, bio-ventures, and patients.
Company Info
- Founded
- 2016
- Website
- www.azothbio.com/
Only accessible to MedStartr community members.
Join nowWhat do you think of AZothBio (에이조스바이오)?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.